TGF-β signaling and epithelial-mesenchymal transition in cancer progression

Current Opinion in Oncology

Volumn 25, Issue 1, 2013, Pages 76-84

  Katsuno, Yoko ^a   Lamouille, Samy ^a   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer stem cell; EMT; Smad; TGF

Indexed keywords

METALLOPROTEINASE; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA;

CANCER GROWTH; CANCER INVASION; CANCER STEM CELL; COMPLEX FORMATION; DOWN REGULATION; ENZYME RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; METASTASIS; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; UPREGULATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84871948755     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32835b6371     Document Type: Review

References (79)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144:646-674
2. Calvo F, Sahai E. Cell communication networks in cancer invasion. Curr Opin Cell Biol 2011; 23:621-629
3. Valastyan S, Weinberg RA. Tumor metastasis: Molecular insights and evolving paradigms. Cell 2011; 147:275-292
4. Nguyen DX, Bos PD, MassaguéJ. Metastasis: From dissemination to organspecific colonization. Nat Rev Cancer 2009; 9:274-284
5. Yilmaz M, Christofori G. Mechanisms of motility in metastasizing cells. Mol Cancer Res 2010; 8:629-642
6. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871-890
7. Xu J, Lamouille S, Derynck R. TGF-b-induced epithelial to mesenchymal transition. Cell Res 2009; 19:156-172
8. Ikushima H, Miyazono K. TGFb signalling: A complex web in cancer progression. Nat Rev Cancer 2010; 10:415-424
9. MassaguéJ. TGFb in cancer. Cell 2008; 134:215-230
10. Shi Y, MassaguéJ. Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 2003; 113:685-700
11. Feng XH, Derynck R. Specificity and versatility in TGF-b signaling through Smads. Annu Rev Cell Dev Biol 2005; 21:659-693
12. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-b family signalling. Nature 2003; 425:577-584
13. Moustakas A, Heldin CH. Non-Smad TGF-b signals. J Cell Sci 2005; 118:3573-3584
14. Yang J, Weinberg RA. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 2008; 14:818- 829
15. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420-1428
16. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-142
17. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7:415-428
18. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28:15-33
19. Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011; 27:347-376
20. Moustakas A, Heldin CH. Signaling networks guiding epithelial- mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98:1512-1520
21. Moustakas A, Heldin CH. Induction of epithelial-mesenchymal transition by transforming growth factor beta. Semin Cancer Biol 2012; 22:446- 454
22. Vincent T, Neve EP, Johnson JR, et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-b mediated epithelial-mesenchymal transition. Nat Cell Biol 2009; 11:943-950
23. Bracken CP, Gregory PA, Kolesnikoff N, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial- mesenchymal transition. Cancer Res 2008; 68:7846-7854
24. Wu CY, Tsai YP, Wu MZ, et al. Epigenetic reprogramming and posttranscriptional regulation during the epithelial-mesenchymal transition. Trends Genet 2012; 28:454-463
25. Horiguchi K, Sakamoto K, Koinuma D, et al. TGF-b drives epithelial- mesenchymal transition through deltaEF1-mediated downregulation of ESRP. Oncogene 2012; 31:3190-3201
26. Shirakihara T, Horiguchi K, Miyazawa K, et al. TGF-b regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J 2011; 30:783-795
27. Lin T, Ponn A, Hu X, et al. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 2010; 29:4896-4904
28. Ezponda T, Popovic R, Shah MY, et al. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene 2012 doi: 10. 1038/onc.2012.297
29. Hayami S, Kelly JD, Cho HS, et al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer 2011; 128:574-586
30. Hudlebusch HR, Santoni-Rugiu E, Simon R, et al. The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res 2011; 17:2919-2933
31. Dong C, Wu Y, Yao J, et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest 2012; 122:1469-1486
32. Kong W, Yang H, He L, et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 2008; 28:6773-6784
33. Zhou Q, Fan J, Ding X, et al. TGF-b-induced miR-491-5p expression promotes Par-3 degradation in rat proximal tubular epithelial cells. J Biol Chem 2010; 285:40019-40027
34. Subramanyam D, Lamouille S, Judson RL, et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 2011; 29:443-448
35. Wang FE, Zhang C, Maminishkis A, et al. MicroRNA-204/211 alters epithelial physiology. FASEB J 2010; 24:1552-1571
36. Zhang J, Ma L. MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 2012; 31:653-662
37. Lamouille S, Derynck R. Cell size and invasion in TGF-b-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 2007; 178:437-451
38. Lamouille S, Connolly E, Smyth JW, et al. TGF-b-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci 2012; 125:1259-1273
39. Chaudhury A, Hussey GS, Ray PS, et al. TGF-b-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 2010; 12:286-293
40. Hussey GS, Chaudhury A, Dawson AE, et al. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell 2011; 41:419-431
41. Vinas-Castells R, Beltran M, Valls G, et al. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J Biol Chem 2010; 285:3794-3805
42. Lander R, Nordin K, LaBonne C. The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1. J Cell Biol 2011; 194: 17-25
43. Araki S, Eitel JA, Batuello CN, et al. TGF-b1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. J Clin Invest 2010; 120:290-302
44. Netherton SJ, Bonni S. Suppression of TGFb-induced epithelial- mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells. PLoS One 2010; 5:e13971
45. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9:265-273
46. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-715
47. Morel AP, Lievre M, Thomas C, et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008; 3:e2888
48. Scheel C, Eaton EN, Li SH, et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011; 145:926-940
49. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003; 3:921-930
50. Kedrin D, Gligorijevic B, Wyckoff J, et al. Intravital imaging of metastatic behavior through a mammary imaging window. Nat Methods 2008; 5:1019- 1021
51. Friedl P. Prespecification and plasticity: Shifting mechanisms of cell migration. Curr Opin Cell Biol 2004; 16:14-23
52. Friedl P, Wolf K. Plasticity of cell migration: A multiscale tuning model. J Cell Biol 2010; 188:11-19
53. Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10:445-457
54. Giampieri S, Manning C, Hooper S, et al. Localized and reversible TGFb signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009; 11:1287-1296
55. Eckert MA, Lwin TM, Chang AT, et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011; 19:372-386.
56. Yamaguchi H, Lorenz M, Kempiak S, et al. Molecular mechanisms of invadopodium formation: The role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 2005; 168:441-452
57. Gligorijevic B, Wyckoff J, Yamaguchi H, et al. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci 2012; 125:724-734
58. Pignatelli J, Tumbarello DA, Schmidt RP, Turner CE. Hic-5 promotes invadopodia formation and invasion during TGF-b-induced epithelial-mesenchymal transition. J Cell Biol 2012; 197:421-437
59. Beach JR, Hussey GS, Miller TE, et al. Myosin II isoform switching mediates invasiveness after TGF-b-induced epithelial-mesenchymal transition. Proc Natl Acad Sci USA 2011; 108:17991-17996
60. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755- 768
61. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105-111
62. Scheel C, Weinberg RA. Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int J Cancer 2011; 129:2310- 2314
63. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983- 3988
64. Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007; 11:259-273
65. Buijs JT, van der Horst G, van den Hoogen C, et al. The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Oncogene 2012; 31:2164-2174
66. Zhang J, Liang Q, Lei Y, et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res 2012; 72:4597-4608
67. Brabletz T, Jung A, Spaderna S, et al. Opinion: Migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5:744-749
68. Cao L, Shao M, Schilder J, et al. Tissue transglutaminase links TGF-b, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene 2012; 31:2521-2534
69. Smith AL, Iwanaga R, Drasin DJ, et al. The miR-106b-25 cluster targets Smad7, activates TGF-b signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012 doi: 10.1038/onc.2012.11
70. Tang B, Yoo N, Vu M, et al. Transforming growth factor-b can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res 2007; 67:8643-8652
71. Ehata S, Johansson E, Katayama R, et al. Transforming growth factor-b decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene 2011; 30:1693-1705
72. Katsuno Y, Ehata S, Yashiro M, et al. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffusetype gastric carcinoma-initiating cells is inhibited by TGF-b. J Pathol 2012; 228:391-404
73. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200:429-447
74. Kojima Y, Acar A, Eaton EN, et al. Autocrine TGF-b and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci USA 2010; 107:20009-20014
75. Zeisberg EM, Potenta S, Xie L, et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 2007; 67:10123-10128
76. Soda Y, Marumoto T, Friedmann-Morvinski D, et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 2011; 108:4274-4280
77. El Hallani S, Boisselier B, Peglion F, et al. A new alternative mechanism in glioblastoma vascularization: Tubular vasculogenic mimicry. Brain 2010; 133:973-982
78. Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010; 468:824-828
79. Wang R, Chadalavada K, Wilshire J, et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010; 468:829-833.